Augmented basal nitric oxide production contributes to maintenance of coronary blood flow in dogs with pacing-induced heart failure

Japanese Heart Journal

Volumn 40, Issue 5, 1999, Pages 629-644

  Niitsuma, Takeo ^a   Saito, Tomiyoshi ^a   Tamagawa, Kazuaki ^a   Saitoh, Shu Ichi ^a   Mitsugi, Minoru ^a   Sato, Masahiko ^a   Maehara, Kazuhira ^a   Maruyama, Yukio ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Coronary circulation; Heart failure; Microcirculation; Nitric oxide; Prostaglandins

Indexed keywords

INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLETE HEART BLOCK; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY PRESSURE; CORONARY VASCULAR RESISTANCE; DIASTOLE; DOG; DOPPLER FLOWMETRY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART OUTPUT; HEART PACING; HEART RIGHT ATRIUM PRESSURE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION;

EID: 0032760988     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/jhj.40.629     Document Type: Article

References (46)

1. Hoffman JIE, Spaan JAE. Pressure-flow relations in coronary circulation. Physiol Rev 1990; 70: 331-90.
2. Watanabe J, Maruyama Y, Satoh S, Keitoku M, Takishima T. Effects of the pericardium on the diastolic left coronary pressure-flow relationship in the isolated clog heart. Circulation 1987; 75: 670-5.
3. Maruyania Y, Takishima T. Effects of ventricular and extraventricular pressure on the coronary artery pressure-flow relationship. In: Kajiya F, Klassen GA, Spaan JAE, Hoffman JIE, editors. Coronary Circulation: Basic Mechanism and Clinical Relevance. Tokyo: Springer-Verlag, 1990: 127-38.
4. Satoh S, Watanabe J, Keitoku M, Itoh N, Maruyama Y, Takishima T. Influences of pressure surrounding the heart and intracardiac pressure on the diastolic coronary pressure-flow relationship in the excised canine heart. Circ Res 1988; 63: 788-97.
5. Aversano T, Klocke FJ, Canty JM Jr. Preload-induced alterations in capacitance-free diastolic pressure-flow relationships. AmJ Physiol 1984; 246: H410-7.
6. Bellamy RF, Lowensohn HS, Ehrlich W, Baer RW. Effects of coronary sinus occlusion on coronary pressure-flow relations. Am J Physiol 1980; 239: H57-64.
7. Mitsugi M, Saito T, Saitoh S, Sato M, Maruyama Y. Effects of synchronized retroperfusion on coronary arterial pressure-flow relationship. Cardiovasc Res 1996; 32: 335-43.
8. Creager MA, Faxon DP, Cutler SS, Kohlmann O, Ryan TJ, Gavras H. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. J Am Coll Cardiol 1986; 7: 758-65.
9. Zelis R, Flaim SF. Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 1982; 24: 437-59.
10. Weiss MB, Ellis K, Sciacca RR, Johnson LL, Schmidt DH, Cannon PJ. Myocardial blood flow in congestive and hypertrophic cardiomyopathy: relationship to peak wall stress and mean velocity of circumferential fiber shortening. Circulation 1976; 54: 484-94.
11. Pasternac A, Noble J, Streulens Y, Elie R, Henschke C, Bourossa MG. Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation 1982; 65: 778-89.
12. Opherk D, Schwarz F, Mall G, MantheyJ, Baller J, Kubler W. Coronary dilated capacity in dilated cardiomyopathy: analysis of 16 patients. Am J Cardiol 1983; 51: 1657-62.
13. Nitenberg A, Foult J-M, Blanchet F, Zouioueche S. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy. Am J Cardiol 1985; 55: 748-54.
14. Cannon III RO, Cunnion RE, Parrillo JE, et al. Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. J Am Coll Cardiol 1987; 10: 1190-200.
15. Wang J, Seyedi N, Xu X, Wolin MS, Hintze TH. Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure. AmJ Physiol 1994; 266: H670-80.
16. Helmer GA, McKirnan MD, Shabetai R, Boss GR, Ross J, Hammond HK. Regional deficits of myocardial blood flow and function in left ventricular pacing-induced heart failure. Circulation 1996; 94: 2260-7.
17. Mohri M, Egashira K, Tagawa T, et al. Basal release of nitric oxide is decreased in the coronary circulation in patients with heart failure. Hypertension 1997; 30[part 1]: 50-6.
18. Larosa G, Armstrong PW, Forster C. Endothelium-dependent relaxations in canine coronary arteries are enhanced in early heart failure and persist in recovery. Can J Physiol Pharmacol 1993; 72: 1148-54.
19. O'Murchu B, Miller VM, Perrella MA, Burnett JC Jr. Increased production of nitric oxide in coronary arteries during congestive heart failure. J Clin Invest 1994; 93: 165-71.
20. Drexler H, Hayoz D, Munzel T, Just H, Zelis R, Brunner HR. Endothelial function in congestive heart failure. Am Heart J 1993; 126: 761-4.
21. Habib F, Dutka D, Crossman D, Oakley CM, Cleland JFG. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet 1994; 344: 371-3.
22. Winlaw DS, Smythe GA, Keogh AM, Schyvens CG, Spratt PM, MacDonald PS. Increased nitric oxide production in heart failure. Lancet 1994; 344: 373-4.
23. Zhao G, Shen W, Xu X, Ochoa M, Bernstein R, Hintze TH. Selective impairment of vagally mediated, nitric oxide-dependent coronary vasodilation in conscious dogs after pacing-induced heart failure. Circulation 1995; 91: 2655-63.
24. Armstrong PW, Stopps TP, Ford SE, DeBold AJ. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation 1986; 74: 1075-84.
25. Steiner C, Kovalek ATW. A simple technique for production of chronic complete heart block in dogs. J Appl Physiol 1968; 25: 631-2.
26. Kennedy JW, Trenholme SE, Kasser IS. Left ventricular volume and mass from single-plane cineangiocardiogram: a comparison of anteroposterior and right anterior oblique methods. Am Heart J 1970; 80: 343-52.
27. Kanamori I, Higuchi T, Yoshida H, Inagawa J, Sasa H, Higuchi O. Fundamental study of Renin IRMA 'Daiichi'. The Journal of Medicine and Pharmaceutical Science 1995; 33: 263-7 (in Japanese).
28. Tsuji T, Masuda H, Imagawa K. Stability of human atrial natriuretic peptide in blood samples. Clin Chim Acta 1994; 225: 171-7.
29. Ando K, Hirata Y, Shichiri M, Emori T, Marumo F. Presence of immunoreactive endothelin in human plasma. FEBS Lett 1989; 245: 164-6.
30. Satoh S, Klocke FJ, Canty JM Jr. Tone-dependent coronary arterial-venous pressure differences at the cessation of venous outflow during long diastoles. Circulation 1993; 88: 1238-44.
31. Dole WP, Bishop VS. Influence of autoregulation and capacitance on diastolic coronary artery pressure-flow relationships in the dog. Circ Res 1982; 51: 261-70.
32. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978; 41: 233-43.
33. Dzau VJ, Colucci WS, Hollenberg NK, Williams GH. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981; 63: 645-51.
34. Wei C-M, Lerman A, Rodeheffer RJ, et al. Endothelin in human congestive heart failure. Circulation 1994; 89: 1580-6.
35. Clavell A, Stingo A, Margulies K, Lerman A, Underwood D, Burnett JC Jr. Physiological significance of endothelin. Its role in congestive heart failure. Circulation 1993; 87[suppl V]: V-45-50.
36. Hintze TH, Shen W, Seyedi N, Zhao G. Potential roles for changes in coronary and myocyte nitric oxide production in the development of heart failure. Heart Failure 1994; 1 16-25.
37. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptor. Trends Pharmacol Sci 1992; 13: 103-8.
38. Haywood GA, Tsao PS, von der Leyen HE, et al. Expression of inducible nitric oxide synthase in human heart failure. Circulation 1996: 93; 1087-94.
39. Jones CJH, Kuo L, Davis MJ, DeFily DV, Chilian WM. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation 1995; 91: 1807-13.
40. Nakaike R, Shimokawa H, Yasutake H, et al. Effects of 1-arginme analogues on vasomotion of isolated porcine coronary arteries. Am J Physiol 1995; 268: H1966-72.
41. Dzau VJ, Packer M, Swartz LS, Hollenberg NK, Willians GH. Prostaglandin in severe congestive heart failure. N Engl J Med 1984; 310: 347-52.
42. Katz SD, Schwarz M, Yuen J, Lejemtel TH. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure: role of endothelium-derived vasodilating and vasoconstricting factors. Circulation 1993; 88: 55-61.
43. Ishihara T, Aisaka K, Hattori Y, et al. Vasodilatory and diuretic actions of alpha-human atrial natriuretic polypeptide. Life Sciences 1985; 36: 1205-15.
44. Tsutamoto T, Kanamori T, Morigami N, Sugimoto Y, Yamaoka O, Kinoshita M. Possibility of downregulation of atrial natriuretic peptide receptor coupled to guanylate cyclase in peripheral vascular beds of patients with chronic severe heart failure. Circulation 1993; 87: 70-5.
45. Mukoyama M, Nakao K. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest 1991; 87: 1402-12.
46. Jougasaki M, Wei C-M, McKinley LJ, Burnett JC Jr. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 1995; 92: 286-9.